NASDAQ:AMIX
Autonomix Medical, Inc.
Autonomix Medical, Inc.'s revenue was $0 in fiscal 2026. Free cash flow was −$12.3M.Summary generated from Autonomix Medical, Inc.'s SEC filings. Latest annual report filed May 27, 2026.
Key statistics
Fiscal 2026 from SEC filings. MethodologyRevenue (FY26)$0
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−238.9%
Debt / equityn/a
Free cash flow−$12.3M
FCF marginn/a
Share count changen/a
Financials
| Item | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Operating income | −2 | −12 | −12 | −17 |
| Net income | −2 | −15 | −11 | −17 |
| Free cash flow | −2 | −7 | −8 | −12 |
Recent filings
- 4Insider transaction report
Sep 21, 2026 - 8-KDirector or officer change
Sep 16, 2026 - DEF 14AProxy statement
Sep 14, 2026 - 4Insider transaction report
Sep 8, 2026 - 8-KEntry into a material agreement
Aug 26, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026 - 8-KOther events
Jul 28, 2026 - 8-KEntry into a material agreement
Jul 15, 2026